WebJun 26, 2024 · More options for people living with rare form of epilepsy. 03-05-2024. JAMA Neurology has published data from a Phase III trial of Fintepla (fenfluramine), the anti-seizure med developed by Brussels-based drugmaker UCB. WebSep 10, 2024 · The company’s first rare disease therapy, FINTEPLA ® (fenfluramine) oral solution, C-IV has been approved by the U.S. FDA, is under review in Europe, and is in development in Japan for the treatment of seizures associated with Dravet syndrome, a rare, severe childhood onset epilepsy.
Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution Now
WebSee GoodRx coupons. Fintepla (fenfluramine) is an antiepileptic (antiseizure) medication that's used for people ages 2 years and older. This medication is only meant for those … WebFeb 8, 2024 · Fintepla is indicated for the treatment of seizures associated with Lennox-Gastaut and Dravet syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older. Fenfluramine is a serotonin releasing agent, and thereby stimulates multiple 5-HT receptor sub-types through the release of serotonin. slow cooker pepper steak and rice
FDA Approves FINTEPLA® (fenfluramine) for the Treatment of …
WebJan 7, 2024 · Fenfluramine is the generic name (non-brand name) of a seizure medicine with the brand name Fintepla® from Zogenix. Fenfluramine is approved for use: In the US, the FDA has approved fenfluramine to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in persons 2 years of age and older. The Committee reminds prescribers and pharmacists dispensing FINTEPLA (fenfluramine) that this proprietary medicinal product is the subject of a controlled access programme associated with prescribing and dispensing specificities, aimed at: 1. 1) preventing the off-label use of FINTEPLA (fenfluramine) for … See more Favourable opinion for reimbursement in the treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older. See more The management of seizures associated with Dravet syndrome is based on the rapid initiation of symptomatic anti-epileptic treatment in order to reduce the frequency, duration and intensity of seizures, taking into … See more Therapeutic improvement in the treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older, like EPIDYOLEX (cannabidiol). See more WebMar 28, 2024 · BRUSSELS and ATLANTA, March 28, 2024 /PRNewswire/ -- UCB (Euronext: UCB), a global biopharmaceutical company, today announced that FINTEPLA ® (fenfluramine) oral solution CIV has been approved... slow cooker pepper steak recipe